Seeking Alpha
Long/short equity, insider ownership
Profile| Send Message|
( followers)  

I screened with Open Insider for insider buy transactions filed on September 28. From this list, I chose the top 5 stocks with insider buying in dollar terms. Here is a look at the top 5 stocks:

1. Republic Services (NYSE:RSG) is an industry leader in the U.S. non-hazardous solid waste industry. Through its subsidiaries, Republic's collection companies, transfer stations, recycling centers and landfills focus on providing reliable environmental services and solutions for commercial, industrial, municipal and residential customers. Republic and its employees believe in protecting the planet and applying common sense solutions to customers' waste and recycling challenges.

(click to enlarge)

Insider buys

Cascade Investment purchased 493,810 shares on September 28, 1,200,773 shares on September 26-27 and 1,648,155 shares on August 1-2. Cascade Investment currently holds 78,043,643 shares of Republic Services. Republic Services has 365,276,656 shares outstanding which makes Cascade Investment a 21.4% owner of Republic Services. Cascade Investment is an American investment company headquartered in Kirkland, Washington, United States. It is controlled by Bill Gates, and managed by Michael Larson.

Financials

The company reported the second-quarter financial results on July 26 with the following highlights:

Revenue$2.1 billion
Net income$0.40 per share
Cash$69 million

Outlook

Republic updated its full year 2012 earnings guidance on July 26:

Adjusted diluted earnings per share is expected to be in a range of $1.91 to $1.93. This guidance assumes a full year effective tax rate of approximately 36.0%. Adjusted diluted earnings per share excludes a number of charges, other expenses and benefits, as described in the 2012 Updated Financial Guidance section of this document.

My analysis

The stock has a $41 price target from the Point and Figure chart. There have been 15 insider buy transactions and eight insider sell transactions this year. The stock is trading at a forward P/E ratio of 13.35. The company has a book value of $21.02 per share. I believe the current share price is a good entry point for the stock.

2. Janus Capital Group (NYSE:JNS) is a global investment firm offering strategies from three individual investment boutiques: Janus Capital Management, INTECH Investment Management and Perkins Investment Management. Each manager employs a research-intensive approach that is distinct within its respective asset class. This multi-boutique approach enables the firm to provide style-specific expertise across an array of strategies, including growth, value and mathematical equities, fixed income and alternatives through one common distribution platform. At the end of June 2012, JCG managed $152.4 billion in assets for shareholders, clients and institutions around the globe. Based in Denver, JCG also has offices in Frankfurt, The Hague, Paris, London, Milan, Munich, Zurich, Singapore, Hong Kong, Tokyo and Melbourne.

(click to enlarge)

Insider buys

Dai Ichi Life Insurance Company purchased 2,748,666 shares on September 27-28, 1,209,429 shares on September 25-26, 1,145,147 shares on September 21-24 and 1,055,052 shares on September 19-20. Dai Ichi Life Insurance Company currently holds 26,566,263 shares of Janus. Janus has 201,329,431 fully diluted shares outstanding which makes Dai Ichi Life Insurance Company a 13.2% owner of Janus.

Financials

The company reported the second-quarter financial results on July 26 with the following highlights:

Revenue$206.0 million
Net income$23.4 million
Cash$638.6 million

My analysis

The stock has a $18 price target from the Point and Figure chart. There have been four insider buy transactions and three insider sell transactions this year. The stock is trading at a forward P/E ratio of 15.48 and has a book value of $7.25 per share. I believe the stock could be a good pick from the current level.

3. Hampton Roads Bankshares (NASDAQ:HMPR) is a bank holding company that was formed in 2001 and is headquartered in Norfolk, Virginia. The company's primary subsidiaries are Bank of Hampton Roads, which opened for business in 1987, and Shore Bank, which opened in 1961. The Banks engage in general community and commercial banking business, targeting the needs of individuals and small to medium-sized businesses. Currently, Bank of Hampton Roads operates banking offices in Virginia and North Carolina doing business as Bank of Hampton Roads and Gateway Bank & Trust Co. Shore Bank serves the Eastern Shore of Maryland and Virginia through seven banking offices, ATMs and a recently opened loan production office in West Ocean City, Maryland. Through various affiliates, the Banks also offer mortgage banking services and investment products.

(click to enlarge)

Insider buys

  • Capgen Capital Group VI LP purchased 11,272,875 shares on September 27 pursuant to a common stock rights offering and currently controls 51,024,981 shares of Hampton Roads Bankshares. Capgen Capital Group VI LP is a 30% owner of Hampton Roads Bankshares.
  • Tcg Financial Services, L.P. purchased 16,007,143 shares on September 27 pursuant to a common stock rights offering and currently controls 42,398,583 shares of Hampton Roads Bankshares. Tcg Financial Services, L.P. is a 24.9% owner of Hampton Roads Bankshares.

Financials

The company reported the second-quarter financial results on July 24 with the following highlights:

Net loss$5.7 million
Book value$1.41 per share
Tangible book value$1.38 per share

My analysis

There have been eight insider buy transactions and there has not been any insider sell transactions this year. I would expect the book value of $1.41 per share to act like a support for the stock.

4. DGT Holdings Corporation (OTCPK:DGTC) previously manufactured proprietary high-voltage power conversion subsystems including electronic filters, high voltage capacitors, pulse modulators, transformers and reactors, and a variety of other products designed for industrial, medical, military and other commercial applications through its Power Conversion Group's RFI Corporation subsidiary. This business was sold on August 16, 2012. The company currently owns and leases two industrial buildings.

(click to enlarge)

Insider buys

Sph Group Holdings purchased 164,625 shares on September 26 and currently holds 2,229,518 shares of DGT Holdings Corporation. Sph Group Holdings is a 58.1% owner of DGT Holdings Corporation.

Financials

The company reported the financial results for its fiscal 2012 year ended July 28, 2012 on September 21 with the following highlights:

Revenue$11.4 million
Net income$5.1 million
Cash$45 million
Debt$2.3 million
Net cash$42.7
Shares outstanding3.8 million
Net cash per share$11.24

My analysis

The stock has a $18.5 price target from the Point and Figure chart. There have been 10 insider buy transactions and there has not been any insider sell transactions this year. The company has a net cash position of $11.24 per share which could be a good entry point for the stock.

5. Opko Health (NYSE:OPK) is a publicly traded healthcare company involved in the discovery, development, and commercialization of pharmaceutical products, vaccines, and diagnostic products.

(click to enlarge)

Insider buys

Phillip Frost purchased 62,500 shares on September 27 and currently controls 132,322,900 shares of the company. The company has 297,836,707 shares outstanding, which makes Mr. Frost a 44.4% owner of the company. Phillip Frost is the CEO and chairman of the company. Mr. Frost has been a buyer almost every day this year. His net worth was $2.4 billion as of September 2012.

Financials

The company reported the second-quarter financial results on August 9 with the following highlights:

Revenue$10.2 million
Net loss$10.8 million
Cash$55.3 million

Upcoming Milestones

  • The company expects to begin marketing its test for Alzheimer's disease in 2013. The company believes that this test could initially be useful in stratifying patients for ongoing clinical trials of potential Alzheimer's drugs, as well as to confirm the diagnosis in a clinical setting and to track the progression of the disease or effectiveness of a therapeutic in a clinical trial.
  • The company has already obtained a CE Mark for its point-of-care diagnostic test for prostate specific antigen [PSA] using its system in Europe, and the company intends to launch the PSA test in Europe in the second half of 2012.
  • In December 2011, the company commenced a multi-center study in the U.S. for the PSA test, which is designed for 510(k) clearance and potential waiver under The Clinical Laboratory Improvement Amendments of 1988. The company intends to submit its application to the Food and Drug Administration for clearance of the PSA test in 2012 and expects to begin marketing the test in the U.S. in 2013.

News

On August 22 OPKO Health was awarded a contract and selected to participate in a development project directed by NASA to implement the OPKO point-of-care diagnostic platform (Claros-1) with the objective of in-orbit use on the International Space Station.

OPKO will provide a panel of assays, including Vitamin D for bone metabolism, immune health, and inflammation to be used on its Claros-1 portable analyzer. According to Phillip Frost, M.D., OPKO's Chairman and Chief Executive Officer:

"This contract is an opportunity to demonstrate the robustness and ease-of-deployment of the OPKO point-of-care system as well as the wide range of complex and high performance diagnostic tests which can be rapidly implemented for use in any environment."

My Analysis

The stock has a $2.75 price target from the Point and Figure chart. The company has several catalysts pending for 2012 and 2013. I would be watching the $4 level closely to see if it holds or not. The 200 day moving average is currently at $4.69 which could act like resistance for the stock. Phillip Frost has been buying 5-10% of the shares traded each day for months already.

Source: Top 5 Stocks With Insider Buys Filed On September 28 To Consider